Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder

Psychiatry Research

Volumn 62, Issue 2, 1996, Pages 131-138

  Koszycki, Diana ^a   Zacharko, Robert M ^b   Bradwejn, Jacques ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Anxiety Sensitivity Index; Introversion; Minnesota Multiphasic Personality Inventory; Panic disorder

Indexed keywords

TETRAGASTRIN;

ADULT; AFFECT; AGORAPHOBIA; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; INTROVERSION; MALE; PANIC; PERSONALITY; PRIORITY JOURNAL; SOMATIZATION;

EID: 0029943299     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02819-3     Document Type: Article

References (21)

1. American Psychiatric Association. (1987) DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. edn. American Psychiatric Press, Washington, DC.
2. Ben-Porath, Y.S., Hostetler, K., Butcher, J.N. and Graham, J.R. (1989). New subscales for the MMPI-2 Social Introversion (Si) scale. Psychological Assessment: A Journal of Consulting and Clinical Psychology 1, 169-174.
3. Bradwejn, J. and Koszycki, D. (1994). The cholecystokinin hypothesis of anxiety and panic disorders. In: Reeve, J.R., Eysselein, V., Solomon, T.E. and Go, V.L.W. (Eds.), Ann NY Acad Sci 173, 273-282.
4. Bradwejn, J., Koszycki, D., Annable, L., Couetoux du Tertre, A., Reines, S. and Karkanias, C. (1992a). A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biol Psychiatry 32, 903-912.
5. Bradwejn, J., Koszycki, D., Payeur, R., Bourin, M. and Borthwick, H. (1992b). Replication of action of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 149, 962-964.
6. Bradwejn, J., Koszycki, D. and Shriqui, C. (1991). Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Arch Gen Psychiatry 48, 603-610.
7. Harro, J., Vasar, R., Koszycki, D. and Bradwejn, J. (1995). Cholecystokinin in panic and anxiety disorders. Adv Biol Psychiatry 1, 235-262.
8. Hathaway, S.R. and McKinley, J.C. (1983). The Minnesota Multiphasic Personality Inventory Manual for Administration and Scoring. University of Minnesota Press, Minneapolis.
9. King, R.J., Mefford, I.N., Wang, C., Murchison, A., Caligari, E.J. and Berger, P.A. (1986). CSF dopamine levels correlate with extraversion in depressed patients. Psychiatry Res 19, 305-310.
10. Koszycki, D., Cox, B.J. and Bradwejn, J. (1993). Anxiety sensitivity and response to CCK-4 in healthy volunteers. Am J Psychiatry 150, 1881-1883.
11. Koszycki, D., Zacharko, R.M., Le Melledo, J.-M., Young, S.N. and Bradwejn, J. (1996) Effect of acute tryptophan depletion on behavioral, cardiovascular and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers. Biol Psychiatry, in press.
12. Lilienfeld, S.O., Turner, S.M. and Jacob, R.G. (1993). Anxiety sensitivity: an examination of theoretical and methodological issues. Adv Behav Res 15, 147-183.
13. Otto, M.W., Pollack, M.H., Sachs, G.S. and Rosenbaum, J.F. (1992). Hypochondriacal concerns, anxiety sensitivity, and panic disorder. J Anxiety Disord 6, 93-104.
14. Pitchot, W., Hansenne, M., Moreno, A.G., von Frenckell, R. and Ansseau, M. (1990). Psychopathological correlates of dopaminergic disturbances in major depression. Neuropsychobiology 91, 169-172.
15. Rapee, R.M., Brown, T.A., Antony, M.M. and Barlow, D.H. (1992). Response to hyperventilation and inhalation of 5.5% carbon dioxide air across the DSM-III-R anxiety disorders. J Abnorm Psychol 3, 538-552.
16. Reiss, S., Peterson, R., Gorsky, D. and McNally, R. (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Therapy 24, 1-8.
17. Uvnäs-Moberg, K., Arn, I., Jonsson, C-O., Ek, S. and Nilsonne, A. (1993). The relationships between personality traits and plasma gastrin, cholecystokinin, somatostatin, insulin, and oxytocin levels in healthy women. J Psychosom Res 37, 581-588.
18. Uvnäs-Moberg, K., Am, I., Theorell, T. and Jonsson, C.-O. (1991). Personality traits in a group of individuals with functional disorders of the gastrointestinal tract and their correlation with gastrin, somatostatin and oxytocin levels. J Psychosom Res 35, 515-523.
19. van Megen, H.J.G.M., Westenberg, H.G.M., den Boer, J.A., Haigh, J.R.M. and Traub, M. (1994). Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114, 449-455.
20. Vasar, E., Peuranen, E., Harro, J., Lang, A., Oreland, L. and Männistö, P.T. (1993). Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn-Schmiedebergs Arch Pharmacol 348, 96-101.
21. Welsh (1956). Factor dimensions A and R. In: Welsh, G. and Dahlstrom, W.G. (Eds.), Basic Readings on the MMPI in Psychology and Medicine. University of Minnesota Press, Minneapolis.